National Resilience, Inc., commonly known as Resilience, is a technology-driven biomanufacturing company focused on advancing the development and production of complex medicines to improve global health.

Founded in 2020, Resilience aims to transform the biopharmaceutical manufacturing industry by offering state-of-the-art, end-to-end solutions. The company operates as a networked biomanufacturing platform, providing partners with advanced technology, expertise, and manufacturing capabilities. Resilience's mission is to ensure that critical therapies are developed and manufactured efficiently, reliably, and at scale, mitigating supply chain risks and fostering innovation in biologics, vaccines, cell and gene therapies, and more. Headquartered in San Diego, California, the company maintains a global footprint with facilities across North America and internationally, including the UAE.

Key Products and Services

• Biologics Manufacturing: Cutting-edge production of complex biologics, including monoclonal antibodies and other therapeutic proteins.
• Cell and Gene Therapy: Development and manufacturing of advanced therapeutics, including gene editing and regenerative medicine products.
• Vaccine Production: Expertise in manufacturing vaccines for infectious diseases and novel applications.
• End-to-End Solutions: Customised services spanning from early-stage development to commercial-scale manufacturing.
• Supply Chain Innovation: Focused on securing and optimising the global biopharma supply chain.

Resilience stands as a forward-thinking leader in the biomanufacturing sector, combining technological innovation with operational excellence. By addressing the complexities of producing advanced therapies, Resilience is reshaping the pharmaceutical landscape and ensuring broader access to lifesaving treatments worldwide. Its initiatives, such as the first GMP biopharma facility in the UAE, underscore its commitment to creating a robust and sustainable life sciences ecosystem for global impact.

National Resilience Inc. continues to innovate within the biopharmaceutical space, ensuring that vital medicines are accessible and produced efficiently. For more information, please visit resilience.com.